
NORWAY – 3i acquires Active Pharmaceutical Ingredients for $395m
3i has backed the buyout of Active Pharmaceuticals Ingredients, an Oslo-based supplier and developer of pharmaceutical ingredients and division of NYSE-listed Alpharma Inc, for $395m.
The business also has production facilities in Copenhagen, Budapest and Taizhou (China). It has long traditions in Norway with roots dating back to 1903. The company has 700 employees and generated approximately $138.7m in revenues in the first nine months of 2007.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top